HomeAI · summaries
Storia in 3 fonti
Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?
Manipal Health Enterprises' large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest, indicating a subdued market sentiment. The company plans to use significant funds for debt repayment and strategic acquisitions. Brokerages largely view Manipal Health's long-term prospects positively, despite premium valuations. The IPO's share allotment is expected in early August 2026.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Indo-MIM IPO GMP at 39%: Issue subscribed over 11x so far on Day 3. Should you apply?
Indo-MIMs Rs 3,811.21 crore IPO received strong investor response on the final day of bidding. The shares are also trading at a grey market premium of around Rs 190, indicating a…
- ·
theprint.in
Manipal Health Enterprises collects Rs 4,167-cr from anchor investors ahead of IPO
New Delhi, Jul 28 (PTI) Manipal Health Enterprises Ltd on Tuesday raised Rs 4,167 crore from anchor investors ahead of the launch of its Rs 9,275-crore initial public offering…
